Longeveron Inc.
LGVN
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$0.95
FAIR PRICE
$0.53
MARGIN
$0.42
P/E Ratio
N/A
Div. Yield
N/A
ROE
-199.8%
Market Cap
$23M
Small-cap
COMING SOON
Get notified when LGVN's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Stephen H. Willard
COUNTRY
US
HEADQUARTERS
Miami
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate LGVN's fair price
Longeveron Inc.'s fair price of $0.53 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%). At the current market price of $0.95, LGVN trades 44.4% above its calculated fair value.
DCF MODEL · 50%
Discounted cash flow analysis based on projected free cash flows, discounted at a rate reflecting LGVN's risk profile.
RELATIVE · 30%
Comparing LGVN's valuation multiples against Healthcare peers.
ANALYST · 20%
Aggregated analyst price targets for LGVN, weighted by recency and analyst accuracy.
POWERED BY BULIOS
Get full analysis, financials, and AI insights for LGVN.
Explore on BuliosFAQ
What is the fair price of LGVN?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Longeveron Inc. is $0.53. At the current market price of $0.95, LGVN trades 44.4% above its calculated fair value.
Is LGVN overvalued or undervalued?+
Longeveron Inc. is currently overvalued based on our valuation model. The stock trades at $0.95, which is 44.4% above the fair price of $0.53.
How often is LGVN's fair price updated?+
We update fair price calculations for LGVN daily after market close. The current fair price of $0.53 incorporates the latest market data and sector multiples.
What factors affect LGVN's fair price calculation?+
LGVN's fair price of $0.53 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of -199.8%.
Is LGVN a good buy right now?+
At $0.95, LGVN trades 44.4% above our fair value estimate of $0.53. The stock is currently overvalued. ROE stands at -199.8% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does LGVN pay dividends?+
LGVN does not currently pay a dividend.